Roger Newton

Dr. Roger Newton is the co-inventor of Lipitor, the most prescribed cholesterol-reducing drug in the world. As President and CEO of Espirion Therapeutics, he led the company to a $1.3B acquisition in 2004. He has worked for over thirty years in the pharmaceutical and biotech life sciences industries. He is currently Executive Chairman and CSO, and most recently, Founder, President/CEO, and Director of Esperion Therapeutics, Inc.